|
|
|
|
| LEADER |
00000cam a2200000Mi 4500 |
| 001 |
ocn923263969 |
| 003 |
OCoLC |
| 005 |
20240909213021.0 |
| 006 |
m o d |
| 007 |
cr |n||||||||| |
| 008 |
151010s1900 dcu o 000 0 eng d |
| 040 |
|
|
|a EBLCP
|b eng
|e pn
|c EBLCP
|d OCLCQ
|d MERUC
|d ZCU
|d ICG
|d OCLCO
|d OCLCF
|d OCLCQ
|d OCLCO
|d OCLCQ
|d LVT
|d DKC
|d AU@
|d OCLCQ
|d OCLCO
|d OCLCQ
|d OCLCO
|d OCLCL
|d OCLCQ
|
| 020 |
|
|
|a 9780309598804
|
| 020 |
|
|
|a 030959880X
|
| 035 |
|
|
|a (OCoLC)923263969
|
| 043 |
|
|
|a n-us---
|
| 050 |
|
4 |
|a RC276.N38
|
| 049 |
|
|
|a HCDD
|
| 100 |
1 |
|
|a Staff, National Research Council.
|
| 245 |
1 |
0 |
|a Risk Assessment in the Federal Government :
|b Managing the Process.
|
| 260 |
|
|
|a Washington :
|b National Academies Press,
|c 1900.
|
| 300 |
|
|
|a 1 online resource (191 pages)
|
| 336 |
|
|
|a text
|b txt
|2 rdacontent
|
| 337 |
|
|
|a computer
|b c
|2 rdamedia
|
| 338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
| 588 |
0 |
|
|a Print version record.
|
| 505 |
0 |
|
|a ""Risk Assessment in the Federal Government: Managing the Process""; ""Copyright""; ""Acknowledgments""; ""Preface""; ""Contents""; ""Risk Assessment in the Federal Government: Managing the Process""; ""Summary""; ""SETTING""; ""STUDY OBJECTIVES AND SCOPE""; ""THE NATURE OF RISK ASSESSMENT""; ""UNIFORM GUIDELINES FOR RISK ASSESSMENT""; ""INSTITUTIONAL ARRANGEMENTS FOR RISK ASSESSMENT""; ""CONCLUSIONS AND MAJOR RECOMMENDATIONS""; ""Introduction""; ""DIFFICULTIES IN DECISION-MAKING""; ""Inherent Limitations""; ""Uncertainty""; ""Limited Analytic Resources""; ""Complexity""
|
| 505 |
8 |
|
|a ""External Pressures""""Public Concern with Health Protection""; ""Visible Economic Interests""; ""Congressional Action""; ""PROPOSED REFORMS""; ""THE STUDY""; ""REFERENCES""; ""I The Nature of Risk Assessment ""; ""TERMINOLOGY""; ""Risk Assessment and Risk Management""; ""Steps in Risk Assessment""; ""Scientific Basis for Risk Assessment""; ""Step 1. Hazard Identification""; ""Epidemiologic Data""; ""Animal-Bioassay Data""; ""Short-Term Studies""; ""Comparisons of Molecular Structure""; ""Step 2. Dose-Response Assessment""; ""Low-Dose Extrapolation""; ""Animal-to-Human Dose Extrapolation""
|
| 505 |
8 |
|
|a ""Step 3. Exposure Assessment""""Step 4. Risk Characterization""; ""SCIENTIFIC AND POLICY JUDGMENTS IN RISK ASSESSMENT""; ""Components of Risk Assessment""; ""The Interplay of Science and Policy in Risk Assessment""; ""Hazard Identification""; ""Dose-Response Assessment""; ""Exposure Assessment""; ""Risk Characterization""; ""Basis for Selecting Inference Options""; ""RISK ASSESSMENT IN PRACTICE""; ""Risk Assessment and Regulatory Decision-Making""; ""The Agencies That Regulate""; ""Organizational Arrangements""; ""Regulatory Statutes""; ""CONCLUSIONS""; ""REFERENCES""
|
| 505 |
8 |
|
|a ""II Inference Guidelines for Risk Assessment """"INTRODUCTION AND DEFINITIONS""; ""HISTORY OF THE USE OF GUIDELINES SAFETY EVALUATION GUIDELINES FOR EFFECTS OTHER THAN CANCER""; ""Guidelines for Carcinogenic Risk""; ""International Agency for Research on Cancer (IARC)""; ""Food and Drug Administration""; ""Environmental Protection Agency""; ""Occupational Safety and Health Administration""; ""Consumer Product Safety Commission""; ""Interagency Regulatory Liaison Group""; ""VARIATION IN THE FORM OF GUIDELINES""; ""Comprehensiveness""; ""Extent of Detail""; ""Flexibility""
|
| 505 |
8 |
|
|a ""Degree To Which Guidelines May Be Binding on An Agency and A Regulated Party""""ARGUMENTS FOR AND AGAINST THE USE OF GUIDELINES""; ""Advantages of Guideline Use""; ""Separation of Risk Assessment from Risk Management""; ""Quality Control""; ""Consistency""; ""Predictability""; ""Evolutionary Improvement of the Risk Assessment Process""; ""Public Understanding""; ""Administrative Efficiency""; ""Disadvantages of Guideline Use""; ""Oversimplification""; ""Mixing of Scientific Knowledge and Risk Assessment Policy""
|
| 500 |
|
|
|a ""Misallocation of Agency Resources to Development and Amendment of Guidelines""
|
| 650 |
|
0 |
|a Cancer
|z United States
|x Prevention
|x Decision making.
|
| 650 |
|
0 |
|a Health planning
|z United States
|x Decision making.
|
| 650 |
|
0 |
|a Health risk assessment.
|
| 650 |
|
0 |
|a Environmentally induced diseases
|z United States
|x Prevention.
|
| 650 |
|
7 |
|a Cancer
|x Prevention
|x Decision making
|2 fast
|
| 650 |
|
7 |
|a Environmentally induced diseases
|x Prevention
|2 fast
|
| 650 |
|
7 |
|a Health planning
|x Decision making
|2 fast
|
| 650 |
|
7 |
|a Health risk assessment
|2 fast
|
| 651 |
|
7 |
|a United States
|2 fast
|1 https://id.oclc.org/worldcat/entity/E39PBJtxgQXMWqmjMjjwXRHgrq
|
| 776 |
0 |
8 |
|i Print version:
|a Staff, National Research Council.
|t Risk Assessment in the Federal Government : Managing the Process.
|d Washington : National Academies Press, ©1900
|z 9780309033497
|
| 856 |
4 |
0 |
|u https://ebookcentral.proquest.com/lib/holycrosscollege-ebooks/detail.action?docID=3376457
|y Click for online access
|
| 903 |
|
|
|a EBC-AC
|
| 994 |
|
|
|a 92
|b HCD
|